Distinguished Domestic Expert in Biopharmaceutical Project Construction Management, with 31 years of deep specialization across chemical pharmaceuticals, biopharmaceuticals, food additives, and electronic chemicals. Focuses on processes for ultra-high purity, ultra-clean, and high-potency compounds, as well as flexible production line configuration. Integrates cross-functional expertise spanning process engineering, quality assurance, equipment engineering, and project management, aligning projects with evolving industry trends and constructability requirements from the initial positioning stage. Spearheaded the delivery of multiple benchmark production lines, including the STA IIa Module Validation, the Wanshu Kilolab API Project, Grand Pharmaceutical’s 150 Million Units Sterile Ophthalmic Solution Production Line, as well as mRNA facilities and OEB4 high-potency compound lines. Delivers end-to-end optimization spanning conceptual design, basic design, and final delivery, consistently maximizing client value and operational reliability across the asset lifecycle.